470 related articles for article (PubMed ID: 30301756)
1. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
[TBL] [Abstract][Full Text] [Related]
2. [Pain and analgesia : Mutations of voltage-gated sodium channels].
Eberhardt MJ; Leffler A
Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
[TBL] [Abstract][Full Text] [Related]
3. Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.
Minett MS; Pereira V; Sikandar S; Matsuyama A; Lolignier S; Kanellopoulos AH; Mancini F; Iannetti GD; Bogdanov YD; Santana-Varela S; Millet Q; Baskozos G; MacAllister R; Cox JJ; Zhao J; Wood JN
Nat Commun; 2015 Dec; 6():8967. PubMed ID: 26634308
[TBL] [Abstract][Full Text] [Related]
4. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
5. Visceral and somatic pain modalities reveal Na
Hockley JR; González-Cano R; McMurray S; Tejada-Giraldez MA; McGuire C; Torres A; Wilbrey AL; Cibert-Goton V; Nieto FR; Pitcher T; Knowles CH; Baeyens JM; Wood JN; Winchester WJ; Bulmer DC; Cendán CM; McMurray G
J Physiol; 2017 Apr; 595(8):2661-2679. PubMed ID: 28105664
[TBL] [Abstract][Full Text] [Related]
6. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
[TBL] [Abstract][Full Text] [Related]
7. Defining the Functional Role of Na
McDermott LA; Weir GA; Themistocleous AC; Segerdahl AR; Blesneac I; Baskozos G; Clark AJ; Millar V; Peck LJ; Ebner D; Tracey I; Serra J; Bennett DL
Neuron; 2019 Mar; 101(5):905-919.e8. PubMed ID: 30795902
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of a rat Nav1.7 loss-of-function model with insensitivity to pain.
Chen L; Effraim PR; Carrara J; Zhao P; Dib-Hajj FB; Dib-Hajj SD; Waxman SG
Pain; 2020 Jun; 161(6):1350-1360. PubMed ID: 31977939
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain.
Beckley JT; Pajouhesh H; Luu G; Klas S; Delwig A; Monteleone D; Zhou X; Giuvelis D; Meng ID; Yeomans DC; Hunter JC; Mulcahy JV
Pain; 2021 Apr; 162(4):1250-1261. PubMed ID: 33086288
[TBL] [Abstract][Full Text] [Related]
10. Novel
Sun J; Li L; Yang L; Duan G; Ma T; Li N; Liu Y; Yao J; Liu JY; Zhang X
Mol Pain; 2020; 16():1744806920923881. PubMed ID: 32420800
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of Nav1.7 functional expression in rat dorsal root ganglia neurons by using an electrical field stimulation assay.
Fouillet A; Watson JF; Piekarz AD; Huang X; Li B; Priest B; Nisenbaum E; Sher E; Ursu D
Mol Pain; 2017; 13():1744806917745179. PubMed ID: 29166836
[TBL] [Abstract][Full Text] [Related]
12. Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain.
Gingras J; Smith S; Matson DJ; Johnson D; Nye K; Couture L; Feric E; Yin R; Moyer BD; Peterson ML; Rottman JB; Beiler RJ; Malmberg AB; McDonough SI
PLoS One; 2014; 9(9):e105895. PubMed ID: 25188265
[TBL] [Abstract][Full Text] [Related]
13. Human Mendelian pain disorders: a key to discovery and validation of novel analgesics.
Goldberg YP; Pimstone SN; Namdari R; Price N; Cohen C; Sherrington RP; Hayden MR
Clin Genet; 2012 Oct; 82(4):367-73. PubMed ID: 22845492
[TBL] [Abstract][Full Text] [Related]
14. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
15. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H.
Vasylyev DV; Han C; Zhao P; Dib-Hajj S; Waxman SG
J Neurophysiol; 2014 Apr; 111(7):1429-43. PubMed ID: 24401712
[TBL] [Abstract][Full Text] [Related]
16. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
Kamei T; Kudo T; Yamane H; Ishibashi F; Takada Y; Honda S; Maezawa Y; Ikeda K; Oyamada Y
Biochem Biophys Res Commun; 2024 Aug; 721():150126. PubMed ID: 38776832
[TBL] [Abstract][Full Text] [Related]
17. Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice.
Isensee J; Krahé L; Moeller K; Pereira V; Sexton JE; Sun X; Emery E; Wood JN; Hucho T
Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074005
[TBL] [Abstract][Full Text] [Related]
18. Na
Wimalasena NK; Taub DG; Shim J; Hakim S; Kawaguchi R; Chen L; El-Rifai M; Geschwind DH; Dib-Hajj SD; Waxman SG; Woolf CJ
Exp Neurol; 2023 Jun; 364():114393. PubMed ID: 37003485
[TBL] [Abstract][Full Text] [Related]
19. Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.
Estacion M; Waxman SG; Dib-Hajj SD
Mol Pain; 2010 Jun; 6():35. PubMed ID: 20529343
[TBL] [Abstract][Full Text] [Related]
20. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
Xue Y; Chidiac C; Herault Y; Gaveriaux-Ruff C
Neurosci Lett; 2021 May; 753():135844. PubMed ID: 33775738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
